FDA clears Johnson & Johnson type 2 diabetes drug Invokana

WASHINGTON, March 29 Fri Mar 29, 2013 3:08pm EDT

WASHINGTON, March 29 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Johnson & Johnson's experimental type 2 diabetes drug Invokana to help patients control their blood sugar.

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article